Open Accessibility Menu

Methodist Digestive Institute

Methodist Digestive Institute – A Hub for Digestive Health Services

If you suffer from a digestive disorder, you are not alone. The National Institutes of Health estimates that 60 to 70 million people suffer from digestive diseases. Because digestive diseases are complex, and symptoms are often subtle and gradual, sufferers commonly endure multiple doctor visits and undergo batteries of tests seeking relief.

A national leader in digestive healthcare, the Methodist Digestive Institute (MDI) at Methodist Dallas Medical Center brings together a multidisciplinary team of physicians, researchers, and health professionals to improve access to services and close the gap between symptom onset and successful treatment. Furthermore, MDI is on the forefront of offering advanced technologies, including minimally invasive and robotic surgery, and incisionless treatment for acid reflux and achalasia.

For more information about any of the services outlined here, call (214) 933-6601.

Conditions We Treat

Colon and rectal diseases - Methodist Dallas became accredited by the National Accreditation Program for Rectal Cancer (NAPRC) in 2022.

  • Colorectal cancer
  • Crohn’s disease
  • Diverticulitis
  • Gastric Cancer
  • Fecal incontinence
  • Hemorrhoids
  • Rectal prolapse
  • Severe constipation

Esophageal diseases and swallowing disorders

  • Achalasia/swallowing disorders
  • Barrett’s esophagus
  • Esophageal cancer
  • Gastric varices
  • Gastroesophageal reflux disease (GERD)
  • Obesity
  • Pancreatic fluid collections
  • Pancreatic cysts
  • Unexplained pancreatitis
  • Chronic pancreatitis
  • Post-cholecystectomy pain
  • Difficult bile duct stones
  • Pancreatic stones
  • Complex bile duct strictures

Inflammatory bowel disease

  • Crohn’s disease
  • Ulcerative colitis

Liver disease

Methodist Dallas Medical Center is home to The Liver Institute, which provides innovative and compassionate care to patients from all over the world.

  • Alcoholic liver disease
  • Autoimmune liver disease
  • Cirrhosis
  • Genetic liver disease
  • Fatty liver (metabolic syndrome)
  • Hepatitis
  • Hepatobiliary tumors
  • Portal hypertension

Pancreatic Disease

Accredited as a National Pancreas Foundation Center of Excellence for:

  • Pancreas Cancer
  • Adult Pancreatitis​​​

*Founded in 1997, the National Pancreas Foundation provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting-edge research, advocating for new and better therapies and providing support and education for patients, caregivers and healthcare professionals. The NPF is the only foundation dedicated to patients suffering from all forms of pancreas disease. For more information visit:

Advanced Technology

Methodist Digestive Institute is known for its technological expertise. Among other things, Methodist Dallas operates as an Epicenter for general and hepatobiliary robotic surgery. Advanced procedures include:


  • Robotic and laparoscopic liver resections
  • Robotic pancreaticduodenectomy (Whipple)
  • Robotic colectomy
  • Robotic protectomy
  • Robotic single-site cholecystectomy (gallbladder removal)
  • Pancreas, liver and kidney transplantation
  • Irreversible electroporation (IRE)

Advanced Interventional Endoscopy

  • Advanced diagnostic ERCP:
    • Confocal laser endomicroscopy
    • Digital cholangioscopy
    • Video laser endomicroscopy
  • Therapeutic ERCP
    • Ampullectomy
    • Laser lithotripsy
    • Transpapillary drainage of pancreatic fluid collections
    • Tumor ablation
    • Bile duct stenting
    • Digital pancreatoscopy
  • Endoscopic suturing
  • Endoscopic mucosal resection
  • Endoscopic retrograde cholangiopancreatography (ERCP)
  • Flexible endoscopic Zenker diverticulum myotomy
  • Peroral endoscopic myotomy (POEM)
  • Transoral incisionless fundoplication (TIF)
  • Endoscopic bariatric procedures
    • Intragastric balloon
    • Sleeve gastroplasty
    • Endoscopic sleeve gastroplasty (ESG)

Interventional Radiology

MDI’s radiopharmaceutical program is designated as a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). This designation is to ensure patients have reliable access to high quality radiopharmaceutical therapy, well-integrated into their pathway of care, delivered by highly qualified therapy teams, at technically qualified sites, and led by physicians appropriately trained in nuclear medicine.

  • Radiofrequency ablation
  • Microwave ablation
  • Chemo-embolization
  • Radioembolization (Selective Internal Radiation Therapy)
    • Y-90 Advanced Treatment Center
  • Peptide Receptor Radionuclide Therapy (PRRT)

Support Services
MDI support

MDI’s support services exemplify the Methodist Health System core value of having a servant’s heart. By compassionately putting others first, we are constantly reminded that healthcare is not one-size-fits-all. It takes a listening ear and a servant’s heart to understand and meet the patient’s needs. Some of the ways we personalize care through support services include:

  • Genetic counseling
  • Nurse navigation for pancreatitis and pancreatic cancer patients
  • Nutrition counseling for both inpatients and outpatients
  • Pain management support
  • Palliative care
  • Psychosocial services
  • Survivorship services

Quality Commitment

In addition to providing personal, multidisciplinary care and advanced technology, MDI works to enhance the health and well-being of patients through continuous quality improvement efforts. These efforts increase providers’ knowledge and understanding of healthcare practices and their contribution to treating disease, and enable patients to access innovative, high-quality services.

Current and past quality improvement initiatives efforts focus on:

  • The impact of mindful stress-reduction interventions on patients anxiety, stress, and pain levels.
  • Implementation of standardized order sets to improve clinical outcomes without increasing costs in patients with acute pancreatitis.
  • Integration of palliative care early in patients with unresectable metastatic pancreatic cancer disease course to improve symptom management, quality-of-life, and patient and caregiver satisfaction.

Clinical Research

Research helps doctors and other providers improve the quality and safety of the care they provide to their patients. It also enables patients’ to have access to high-quality and novel treatment options. MDI participates in this process by collecting and analyzing data on the progress of our patients in order to compare the effectiveness of different treatments for the same disease or condition, to evaluate different approaches to a procedure, or to see what factors influence patient experience. All patient information is blinded and aggregated to protect patient privacy.

Click here to download our current clinical research.

Virtual Physician Lecture Series

The Methodist Digestive Institute presents a lecture series with physicians in mind. View our on-demand content here.

learn more about our virtual physician lecture series